《美股业绩》星巴克上季少赚近30% 同店销售降5%逊预期
星巴克(SBUX.US)截至12月27日止首财季盈利倒退29.8%至6.22亿美元,每股经调整後盈利为0.61元,优於市场预期的0.55元。收入下跌近5%至67.5亿美元,未达市场预期的69.3亿美元。
季内星巴克全球同店销售下降5%,分析师原预期为下降3.4%,因美国再次新冠病毒确诊病例激增,令消费者留在家中。
季内美洲地区同店销售下降6%,较市场预期的5.2%为差,而中国市场则增长5%。星巴克维持今财年全球同店销售将增长18%至23%的目标,预计第二季度美国销售将增长5%至10%,而中国则会有一倍的增幅。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.